As of 2025-08-03, the Intrinsic Value of Vitality Biopharma Inc (VBIO) is -0.09 USD. This VBIO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.23 USD, the upside of Vitality Biopharma Inc is -138.44%.
Based on its market price of 0.23 USD and our intrinsic valuation, Vitality Biopharma Inc (VBIO) is overvalued by 138.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.09 - -0.09 | -0.09 | -138.44% |
| DDM - Stable | (0.16) - (5.57) | (2.86) | -1372.9% |
| DDM - Multi | (0.18) - (4.94) | (0.35) | -255.6% |
| Market Cap (mil) | 13.22 |
| Beta | 4.24 |
| Outstanding shares (mil) | 58.77 |
| Enterprise Value (mil) | 12.90 |
| Market risk premium | 4.24% |
| Cost of Equity | 6.87% |
| Cost of Debt | 5.00% |
| WACC | 5.26% |